NCT03474562View on ClinicalTrials.gov

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

June 7, 2019

Study Completion Date

June 7, 2019

Conditions
ASCVDImpaired Fasting GlucoseHypertension
Interventions
DRUG

Duowell®

Telmisartan/Rosuvastatin 40/20mg (increased to Telmisartan 80mg if SBP \> 140mmHg or DBP \> 90mmHg at week 12)

DRUG

Monorova® + Amlopin®

Rosuvastatin 20mg + Amlodipine 5mg (increased to Amlodipine 10mg if SBP \> 140mmHg or DBP \> 90mmHg at week 12)

Trial Locations (4)

Unknown

CHA Bundang Medical Center, Seongnam-si

Dankook University Hospital, Cheonan

Gangnam Severance Hospital, Seoul

Severance Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT03474562 - High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension | Biotech Hunter | Biotech Hunter